1350426-32-2

Basic information

• Product Name: methyl 2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]-triazolo[4,5-b]pyridin-5-yl)benzoate
• Synonyms: methyl 2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]-triazolo[4,5-b]pyridin-5-yl)benzoate
• CAS NO: 1350426-32-2
• Molecular Weight: 413.411
• Mol File: 1350426-32-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]-triazolo[4,5-b]pyridin-5-yl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]-triazolo[4,5-b]pyridin-5-yl)benzoate(1350426-32-2)
• EPA Substance Registry System: methyl 2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]-triazolo[4,5-b]pyridin-5-yl)benzoate(1350426-32-2)

Safety Data

• Hazardous Substances Data: 1350426-32-2(Hazardous Substances Data)

Upstream product

• 38896-30-9 6-(methoxycarbonyl)quinoline 
• 150-13-0 4-amino-benzoic acid 
• 10349-57-2 Quinoline-6-carboxylic acid 
• 505083-04-5 3-fluoro-4-methoxycarbonylphenylboronic acid 
• 1313726-84-9 6-((5-chloro-3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)methyl)quinoline 
• 1350425-96-5 6-chloro-N²-(quinolin-6-ylmethyl)pyridine-2,3-diamine 
• 1350425-92-1 6-chloro-3-nitro-N-(quinolin-6-ylmethyl)pyridin-2-amine 
• 99071-54-2 quinolin-6-ylmethanamine 
• 23395-72-4 quinoline-6-carbonitrile 
• 5382-43-4 quinoline-6-carboxamide 

Downstream Products

• 1350426-51-5 N-(2-(dimethylamino)ethyl)-2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)benzamide 
• 1350427-40-5 N-(3-Aminopropyl)-2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)benzamide 
• 1350426-81-1 3-(2-Fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)phenylamino)propanoic acid 
• 1350426-80-0 Methyl 3-(2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)phenyl amino)propanoate 
• 1350426-74-2 2-(2-Fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)benzamido)acetic acid 
• 1350426-73-1 Methyl 2-(2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)benzamido)acetate 
• 1350426-66-2 N-ethyl-2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)benzamide 
• 1350426-65-1 6-((5-(3-Fluoro-4-(methoxymethyl)phenyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)methyl)quinoline 
• 1350426-36-6 (2-Fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)phenyl)methanol 
• 1350426-35-5 2-Fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)benzamide 
• 1350426-34-4 2-Fluoro-N-methyl-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-yl)benzamide 
• 1350426-33-3 2-fluoro-4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]-triazolo[4,5-b]pyridin-5-yl)benzoic acid 

Relevant articles and documents

NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES

The present invention provides compounds useful as C-met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of C-met kinase mediated diseases or disorders with them.